SGMO
Sangamo Therapeutics Inc
Price:  
0.74 
USD
Volume:  
4,448,228.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SGMO WACC - Weighted Average Cost of Capital

The WACC of Sangamo Therapeutics Inc (SGMO) is 8.3%.

The Cost of Equity of Sangamo Therapeutics Inc (SGMO) is 11.60%.
The Cost of Debt of Sangamo Therapeutics Inc (SGMO) is 5.00%.

Range Selected
Cost of equity 8.30% - 14.90% 11.60%
Tax rate 0.20% - 0.20% 0.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.6% - 10.0% 8.3%
WACC

SGMO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.96 1.8
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.30% 14.90%
Tax rate 0.20% 0.20%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.6% 10.0%
Selected WACC 8.3%